Regulation & global markets
Pathways, authorities, conformity and local responsibilities.
AUPAM / MEDICAL TECHNOLOGY
A working hub for medical devices: market access, quality, IVDs, digital health, procurement, traceability, safety updates and official references.
For manufacturers, regulatory teams, quality professionals, purchasers and clinical engineers.
Compare 12 markets, select your product and keep a source-linked action plan.
For regulatory teams, manufacturers, researchers, purchasers, clinical engineers and learners — connected through original sources and practical work.
Regulators, standards, research methods and literature databases.
Open workspace ↗02 / Learning academy12 modules, 24 scenarios and a saved learning record.
Open workspace ↗03 / Evidence workspaceA literature-search builder and an editable evidence log.
Open workspace ↗04 / Practical toolkit8 worksheets, local saving, export and print.
Open workspace ↗Fourteen routes into the reference library and related lessons.
Pathways, authorities, conformity and local responsibilities.
Performance evidence, procurement and diagnostic-study reporting.
Software evidence, change control and authorization scope.
Quality systems, standards, test laboratories and evidence.
Cleaning, sterilisation, packaging and device-specific instructions.
Contact, finished-device evidence and follow-up questions.
Applicable testing, intended use, AI and maintenance records.
Materials, reprocessing and a traceable quality file.
Supplier evidence, consumables, lifecycle cost and acceptance.
Inventory, service, repair support and end-of-life decisions.
System planning, technical resources and service requirements.
User needs, access, usability and service provision.
Official alerts, identifiers and careful interpretation of reports.
Search, critical appraisal, reporting and value assessment.
A practical route through the full product lifecycle.
Choose a jurisdiction and find its original requirements.
Start here ↗02Organise the evidence behind your device and its claims.
Start here ↗03Qualify suppliers, plan total cost and preserve traceability.
Start here ↗04Follow published alerts, maintenance and lifecycle needs.
Start here ↗Jurisdiction-specific entry points. Always read the current source.
Check the intended use, product code and classification. Depending on the device, the route may be exempt, 510(k), De Novo or PMA. Establishment registration is a separate obligation.
Use MDR for medical devices and IVDR for in vitro diagnostics. Confirm the applicable classification, conformity assessment route and economic-operator responsibilities. Check transitional eligibility in the current legal text.
Check the destination first. Great Britain requires MHRA registration before placement on the market, with a UK Responsible Person for overseas manufacturers. Accepted marking and transition dates depend on the applicable route.
Use MDALL to check Class II, III and IV device licences. Match the exact device and manufacturer, and distinguish an active licence from an archived entry. A record can change status.
Review intended purpose, risk class and evidence of conformity. Identify the Australian sponsor and the appropriate ARTG inclusion route or applicable exception. The framework covers IVDs as well as other devices.
Start with the SFDA medical-device marketing authorisation requirements and current attachments. Confirm product scope, classification, the responsible local entity and submission requirements for the specific device.
The route depends on risk class and whether certification standards exist. Confirm the role of the Japanese marketing authorisation holder and the applicable PMDA/MHLW procedure.
Choose a product type, review the relevant prompts and export your working checklist.
Evidence preparation only; this is not a compliance score or approval.
Define claims, user, patient population and use environment.
Record the target market, applicable rule and classification rationale.
Match names, model numbers, accessories and version boundaries.
Connect hazards, controls, verification and remaining risk.
Identify design, manufacturing, supplier and change-control responsibilities.
Map each claim to suitable test, clinical or performance evidence.
Check intended purpose, warnings, languages and product identifiers.
Verify the actual authorisation or conformity route and its scope.
Link units, lots or versions to distribution records and response owners.
Assign review of modifications, post-market information and corrective actions.
Document the validated process, release evidence and applicable residuals.
Check packaging integrity, distribution conditions and ageing evidence.
Assess biological risks for the contact type and duration.
Use product-specific stability evidence, storage limits and in-use conditions.
Identify applicable electrical, electromagnetic and interoperability evidence.
Prepare acceptance criteria, service arrangements and critical spare parts.
Evaluate critical user tasks, foreseeable misuse and training needs.
Document sample handling, measuring range, interference and precision as relevant.
Define population, comparator and evidence supporting the intended clinical role.
Plan calibration, quality controls, lot verification and user competence.
Track requirements, architecture, testing, anomalies and release versions.
Where connected or cyber-enabled, review threats, components, updates and support.
For AI functions, document data relevance, performance limits and change review.
Record the evidence reference, reviewer and any non-applicability rationale in the exported worksheet. Apply device-specific requirements; the list is a starting point.
Connect design, suppliers, manufacture, release and post-market evidence.
US QMSR has applied since 2 February 2026. Confirm the applicable requirements and exemptions.
Quality Management System RegulationKeep risk controls linked to verification and information from actual use.
ISO 14971 — risk managementMap the relevant essential principles to product-specific evidence.
Essential safety & performance principlesCheck the edition, recognised scope and local legal role of each standard.
ISO 13485 — quality managementFor the technical file, assess applicable biological, electrical, software, sterilisation, packaging and usability evidence. A standards certificate does not replace product authorisation. Full standards remain with their licensed publishers.
A procurement worklist for equipment, supplies, reagents and their supporting services.
Define the clinical task, setting, capacity and compatible consumables.
Verify identity, authorisation scope, quality arrangements and service capability.
Compare evidence, availability, consumables, training and lifetime costs.
Match licences, invoices, models, quantities and transport requirements.
Check packaging, expiry, identifiers, supplied documents and acceptance tests.
Apply the manufacturer’s product-specific limits; retain delivery traceability.
Maintain calibration, preventive service, compatible spares and contingency plans.
Trace affected units, document action and plan safe decommissioning.
Compare one equipment package over the chosen period. Use one currency; values are your inputs, not market quotations. No inflation, discounting or financing is included.
Keep identifiers tied to the actual product, its version and its distribution history.
Four modules became mandatory on 28 May 2026: actors, UDI/devices, notified bodies/certificates and market surveillance. The market-surveillance module is for competent authorities and the Commission. Other modules follow a different rollout.
EUDAMEDUse the product-specific checklist and follow the applicable jurisdiction.
Look beyond the analyser: sample handling, reagents, controls, calibration, stability, lot verification and laboratory capacity belong in the plan.
IVD & laboratory procurementConnect the intended medical function with software verification, cybersecurity, supported versions and post-market change control.
Device cybersecurity guidanceAssess compatibility, patient contact, sterile barrier, shelf life and reprocessing instructions for the actual intended use.
Essential safety & performance principlesOriginal source date, actual site addition and server monitoring are shown separately.
Loading device-related records…
This view draws from the existing published news, enforcement, radar and executive-digest records, with duplicate source links combined. Source monitoring is not proof of a new publication or of complete device coverage in every market.
Official publishers, a clear purpose for each link, and filters that follow your work.
Start with intended use, classification and the applicable US pathway.
Reference link checked: 3 October 2026US QMSR, effective 2 February 2026; incorporates ISO 13485:2016 by reference.
Reference link checked: 3 October 2026Classification, 510(k), PMA, De Novo, identifiers and safety-report databases.
Reference link checked: 3 October 2026Open the original action and affected-product details.
Reference link checked: 3 October 2026Final guidance, February 2026: design, labelling and submission considerations.
Reference link checked: 3 October 2026Official learning modules across the device lifecycle.
Reference link checked: 3 October 2026Official legislation, amendments and implementation resources.
Reference link checked: 3 October 2026Actor, device, certificate and market-surveillance modules; check each module’s scope.
Reference link checked: 3 October 2026Select the applicable topic, revision and final or draft status.
Reference link checked: 3 October 2026Great Britain and Northern Ireland have different regulatory arrangements.
Reference link checked: 3 October 2026Check Class II, III and IV device licences and distinguish current from archived records.
Reference link checked: 3 October 2026Intended purpose, risk classification, conformity assessment and ARTG inclusion.
Reference link checked: 3 October 2026Official MDS-REQ 1 entry point and its attached requirements.
Reference link checked: 3 October 2026Class-specific notification, certification or approval routes and local responsibilities.
Reference link checked: 3 October 2026International regulatory convergence documents, with final and archived versions.
Reference link checked: 3 October 2026A reference framework for devices and IVDs; national implementation still matters.
Reference link checked: 3 October 2026Publisher overview of ISO 13485. Access to the full standard may require a licence.
Reference link checked: 3 October 2026Publisher description of the device risk-management standard.
Reference link checked: 3 October 2026WHO procurement resource guide, 2011; a planning resource, not a market authorisation.
Reference link checked: 3 October 2026Guidance for procurement of IVDs and related laboratory items and equipment.
Reference link checked: 3 October 2026Publication dates belong to the original documents. The check date is not a new edition date. Guidance, legislation and standards have different legal roles; open the original source for the current version.
A learning route for regulatory, quality, procurement and technical teams.
Define purpose, classification and the destination market.
Open learning sourceMap safety and performance requirements to evidence.
Open learning sourceReview the specification, supplier and full ownership cost.
Open learning sourceUse official modules to deepen a topic and verify its revision.
Open learning sourceLoading the event register…
A single entry point to the Office’s tools, workflows and related content.
Explore the existing device tools; confirm outputs against current national requirements.
Open resource ↗EXISTING OFFICE RESOURCEOpen the Office’s existing device review prompts and reference workflow.
Open resource ↗EXISTING OFFICE RESOURCEOrganise checks of issuer, scope, dates and product traceability.
Open resource ↗EXISTING OFFICE RESOURCEUse the existing supply tools with product-specific assumptions.
Open resource ↗EXISTING OFFICE RESOURCEReview identity, supply-chain evidence and escalation routes.
Open resource ↗EXISTING OFFICE RESOURCEConnect an authority question to evidence, owner and action.
Open resource ↗Clear scope helps you use the information correctly.
No. The market pathway and checklist help organise a review. The intended purpose, applicable rules and competent authority determine the regulatory route.
Treat establishment registration, product listing, clearance, certification and approval as distinct records. Verify the exact product and decision.
The intended purpose and local definitions matter. A laboratory item, protective product, accessory or software function may fall under different rules.
Read the original notice for the exact model, lot, serial number, version, geography and action. Do not generalise beyond its stated scope.
The published-record panel reads the existing site feeds and server status. Reference pages and checklists show their editorial check date; this does not mean every external source is automatically imported.
Editorial and reference-link review: 3 October 2026. This hub supports professional evidence preparation and source navigation.
Editorial standards & corrections ↗Back to top ↑From source to practice
16 guides across quality, manufacture, registration, safety and research, with scope, source versions and saveable working checklists.